Page 32 - B Program News Today

Some pharmaceutical companies have taken measures that could undermine 340B Drug Pricing Program.

Total GAAP revenues of $291 million GAAP net loss per diluted share of $0.33 Non-GAAP net income per diluted share of $0.39 ... | May 2, 2023

Joe Biden's migration agency has recognized blatant fraud in the visa worker program used to divert wealth from myriad U.S. graduates.

Joe Biden's migration agency has recognized blatant fraud in the visa worker program used to divert wealth from myriad U.S. graduates.

Joe Biden's migration agency has recognized blatant fraud in the visa worker program used to divert wealth from myriad U.S. graduates.

The American Conference Institute is hosting the 21st Annual Rx Drug Pricing Boot Camp in New York. With both federal and state law makers engaging in greater scrutiny of prescription...

As detailed further in our article on the current state of the 340B Program and what to expect in 2023, a growing list of manufacturers have taken the step of significantly restricting...

Critical decisions before courts and legislators in 2023 shape future of 340B Drug Pricing Program that provides discounts on outpatient drugs for covered entities. Financial impact on health care industry pharmaceutical manufacturers 340B hospitals and federal grantees.

Critical decisions are pending before courts and legislators in 2023 that promise to shape the future of the 340B Drug Pricing Program (340B Program), which provides discounts...

Johnson, Spanberger Introduce Bipartisan Bill to Protect 340B Program, Prevent Higher Drug Prices Washington, D.C. – Today, U.S. Representatives Dusty Johnson (R-S.D.) and Abigail Spanberger (D-VA-07) introduced a bipartisan bill that would prohibit health insurers and PBMs from discriminating against 340B Drug Pricing Program providers or their contract pharmacies on the basis of their status…